New gel could help cancer patients ditch steroid creams
NCT ID NCT04087629
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a special gel called StrataCTX can help people with skin reactions from cutaneous T-cell lymphoma (CTCL) or cancer treatments use less steroid cream. Steroid creams can have side effects when used a lot, so finding an alternative is important. The study will enroll 70 adults and measure itching and quality of life over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- StrataCTX gel (a flexible wound dressing)
- What this could lead to
- If it works, this could offer a way to manage skin reactions with less reliance on steroid creams, potentially reducing side effects from long-term steroid use.
- What could go wrong
- This is an early, small study (70 people) without a comparison group, so results may not be conclusive. The gel is a device, not a drug, so its effect may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CTCL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Columbia University Irving Medical Center
RECRUITINGNew York, New York, 10032, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.